Literature DB >> 15196262

Anti-desmoglein 1 antibodies in Tunisian healthy subjects: arguments for the role of environmental factors in the occurrence of Tunisian pemphigus foliaceus.

M Kallel Sellami1, M Ben Ayed, H Mouquet, L Drouot, M Zitouni, M Mokni, M Cerruti, H Turki, B Fezza, I Mokhtar, A Ben Osman, A Zahaf, M R Kamoun, P Joly, H Masmoudi, S Makni, F Tron, D Gilbert.   

Abstract

Pemphigus foliaceus is an autoimmune blistering skin disease mediated by autoantibodies directed against desmoglein 1 and occurs as a sporadic form throughout the world, or as an endemic form called fogo selvagem in Brazil. Healthy subjects living in Brazilian endemic areas produce antidesmoglein 1 antibodies, suggesting the role of environmental factors in the initiation of the autoimmune response. Tunisia was described recently as an endemic area where the disease is characterized by its high rate among young people, especially women. An enzyme-linked immunosorbent assay using recombinant desmoglein 1 as antigen was used to detect antibodies against desmoglein 1 and calibrated with sera from 67 French healthy blood donors, 20 French pemphigus foliaceus patients and patients with other bullous skin diseases. When sera from 179 healthy Tunisian blood donors were tested, 31 (17%) were found positive. The desmoglein 1 binding activity of these 31 sera was confirmed in 10 cases by indirect immunofluorescence analysis and/or immunoblotting using human epidermal extract. Subclass analysis of antidesmoglein 1 antibodies showed that they were almost exclusively of the IgG2 subclass in positive normal sera and of IgG4 subclass in patients with PF. Thus, antibodies against desmoglein 1 are prevalent in normal subjects living in Tunisia which, along with their IgG2 isotype, suggests the role of the environment in the pathogenesis of this endemic type of pemphigus foliaceus and the need for additional factors to switch from a subclinical to a clinical form of the disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196262      PMCID: PMC1809068          DOI: 10.1111/j.1365-2249.2004.02493.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research.

Authors:  S J Warren; M S Lin; G J Giudice; R G Hoffmann; G Hans-Filho; V Aoki; E A Rivitti; V Santos; L A Diaz
Journal:  N Engl J Med       Date:  2000-07-06       Impact factor: 91.245

2.  The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives.

Authors:  D Kricheli; M David; M Frusic-Zlotkin; D Goldsmith; M Rabinov; J Sulkes; Y Milner
Journal:  Br J Dermatol       Date:  2000-08       Impact factor: 9.302

3.  Immunoblot analyses of Brazilian pemphigus foliaceus antigen using different antigen sources.

Authors:  M M Ogawa; T Hashimoto; A Konohana; R M Castro; T Nishikawa
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

4.  Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease.

Authors:  G J Anhalt; R S Labib; J J Voorhees; T F Beals; L A Diaz
Journal:  N Engl J Med       Date:  1982-05-20       Impact factor: 91.245

5.  The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus.

Authors:  S J P Warren; L A Arteaga; E A Rivitti; V Aoki; G Hans-Filho; B F Qaqish; M S Lin; G J Giudice; L A Diaz
Journal:  J Invest Dermatol       Date:  2003-01       Impact factor: 8.551

6.  Natural infection of man with group A streptococci. Levels; restriction in class, subclass, and type; and clonal appearance of polysaccharide-group-specific antibodies.

Authors:  W F Riesen; F Skvaril; D G Braun
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

7.  IgG2 subclass restriction of antibody to pneumococcal polysaccharides.

Authors:  D J Barrett; E M Ayoub
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

Review 8.  Endemic pemphigus foliaceus (Fogo Selvagem): II. Current and historic epidemiologic studies.

Authors:  L A Diaz; S A Sampaio; E A Rivitti; C R Martins; P R Cunha; C Lombardi; F A Almeida; R M Castro; M L Macca; C Lavrado
Journal:  J Invest Dermatol       Date:  1989-01       Impact factor: 8.551

9.  Experimentally induced pemphigus vulgaris in neonatal BALB/c mice: a time-course study of clinical, immunologic, ultrastructural, and cytochemical changes.

Authors:  Y Takahashi; H P Patel; R S Labib; L A Diaz; G J Anhalt
Journal:  J Invest Dermatol       Date:  1985-01       Impact factor: 8.551

10.  Human autoantibodies against a desmosomal core protein in pemphigus foliaceus.

Authors:  L Koulu; A Kusumi; M S Steinberg; V Klaus-Kovtun; J R Stanley
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more
  7 in total

1.  Screening the full leucocyte receptor complex genomic region revealed associations with pemphigus that might be explained by gene regulation.

Authors:  Ticiana Della Justina Farias; Danillo G Augusto; Rodrigo Coutinho de Almeida; Danielle Malheiros; Maria Luiza Petzl-Erler
Journal:  Immunology       Date:  2018-10-11       Impact factor: 7.397

Review 2.  From Insect Bites to a Skin Autoimmune Disease: A Conceivable Pathway to Endemic Pemphigus Foliaceus.

Authors:  Ning Li; Valeria Aoki; Zhi Liu; Phillip Prisayanh; Jesus G Valenzuela; Luis A Diaz
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

3.  Autoimmune reactivity against precursor form of desmoglein 1 in healthy Tunisians in the area of endemic pemphigus foliaceus.

Authors:  Amina Toumi; Marwah Adly Saleh; Jun Yamagami; Olfa Abida; Maryem Kallel; Abderrahmen Masmoudi; Sondes Makni; Hamida Turki; Takahisa Hachiya; Keiko Kuroda; John R Stanley; Hatem Masmoudi; Masayuki Amagai
Journal:  J Dermatol Sci       Date:  2013-02-19       Impact factor: 4.563

4.  Endemic pemphigus in the Peruvian Amazon: epidemiology and risk factors for the development of complications during treatment.

Authors:  Willy Ramos; Gina Rocio Chacon; Carlos Galarza; Ericson Leonardo Gutierrez; Maria Eugenia Smith; Alex Gerardo Ortega-Loayza
Journal:  An Bras Dermatol       Date:  2012 Nov-Dec       Impact factor: 1.896

Review 5.  Pemphigus group: overview, epidemiology, mortality, and comorbidities.

Authors:  Khalaf Kridin
Journal:  Immunol Res       Date:  2018-04       Impact factor: 2.829

6.  Endemic pemphigus foliaceus over a century: Part I.

Authors:  Ana María Abréu-Vélez; Iara J de Messias Reason; Michael S Howard; Ana Maria Roselino
Journal:  N Am J Med Sci       Date:  2010-02

7.  A survey of bullous diseases in a Turkish university hospital: clinicoepidemiological characteristics and follow-up

Authors:  Zekayi Kutlubay; Ayşegül Sevim Keçici; Uğur Çelik; Mehmet Cem Mat
Journal:  Turk J Med Sci       Date:  2021-02-26       Impact factor: 0.973

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.